Sunahara J F, Gora-Harper M L, Nash K S
Department of Veterans Affairs, Lexington, KY, USA.
Ann Pharmacother. 1996 May;30(5):484-6. doi: 10.1177/106002809603000510.
To describe a patient who was diagnosed with Raynaud's phenomenon, was prescribed immediate-release nifedipine, and developed a possible erythromelalgia-like syndrome.
A 24-year-old white woman with a history of esophageal spasms and Raynaud's phenomenon was prescribed nifedipine 10 mg po qid. Approximately 1 hour after the patient had taken the fourth dose of nifedipine, she experienced acute erythema and a burning sensation in her feet and lower limbs, light-headedness, and palpitations. Because of a reportedly abnormally low blood pressure, the patient took diphenhydramine 50 mg po and proceeded to the clinic. On arrival, abnormal vital signs were BP 140/48 mm Hg and HR 130 beats/min. Without any other medical intervention, approximately 30 minutes later her blood pressure and heart rate had returned to baseline at 122/60 mm Hg and 96 beats/min, respectively. The nifedipine was permanently discontinued and the patient's symptoms completely resolved over 24 hours.
The characteristic symptoms of erythromelalgia include burning pain, increased skin temperature, and erythema of the extremities, usually to the feet, lower legs, and, less often, the hands. Erythromelalgia-like syndromes secondary to the administration of many medications have been reported. Several nifedipine-related reports describe an erythromelalgia-like syndrome similar to our reported case.
Because the patient was not taking any other medications and the symptoms started with the administration of nifedipine and were relieved after its discontinuation, nifedipine was thought to be the cause of the erythromelalgia-like syndrome.
描述一名被诊断为雷诺现象的患者,该患者服用了硝苯地平速释片,并出现了一种可能类似红斑性肢痛症的综合征。
一名24岁有食管痉挛和雷诺现象病史的白人女性,被开了硝苯地平10毫克口服,每日四次。在患者服用第四剂硝苯地平约1小时后,她感到足部和下肢急性红斑、烧灼感、头晕和心悸。据报道由于血压异常低,患者口服了50毫克苯海拉明并前往诊所。到达时,异常生命体征为血压140/48毫米汞柱,心率130次/分钟。在没有任何其他医疗干预的情况下,大约30分钟后她的血压和心率分别恢复到基线水平,即122/60毫米汞柱和96次/分钟。硝苯地平被永久停用,患者的症状在24小时内完全缓解。
红斑性肢痛症的特征性症状包括灼痛、皮肤温度升高和四肢红斑,通常累及足部、小腿,较少累及手部。已有报道多种药物给药后继发类似红斑性肢痛症的综合征。几篇与硝苯地平相关的报告描述了一种与我们报告的病例相似的类似红斑性肢痛症的综合征。
由于患者未服用任何其他药物,症状始于服用硝苯地平,停药后缓解,因此认为硝苯地平是类似红斑性肢痛症综合征的病因。